← All stories
Deals
Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO
2 outlets - including Investing and Financialpost - are covering this story. Attovia Therapeutics Inc. shares jumped 24% in its trading debut, after the early-stage drug developer focused on immune system diseases raised $289 million in a US initial public offering.
Covered by 2 outlets
All coverage · 2 articles
Investing.com Stock Market
·Aug 5, 16:55 UTC
Attovia Therapeutics shares jump 24% in trading debut after IPO
Financial Post
·Aug 5, 16:53 UTC
Biotech Attovia Therapeutics Climbs 24% After $289 Million IPO
Attovia Therapeutics Inc. shares jumped 24% in its trading debut, after the early-stage drug developer focused on immune system diseases raised $289 million in a US initial public offering.